H.R. 4619
Referred to CommitteePharmaceutical REPAI Act
Introduced 10/8/2019•116th Congress•House
Latest Action
Referred to the Subcommittee on Health.
10/9/2019 • House
Summary
Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act
This bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.
Introduced in House • 10/8/2019
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Business recordsCivil actions and liabilityGovernment information and archivesGovernment trust fundsHealth care costs and insuranceInflation and pricesMedicarePrescription drugs
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (3)
Party Breakdown
3
Democrats
0
Republicans
0
Independents
Sponsor
R[
Cosponsors (2)
R[
R[
Bill Journey
Originated in the House
Introduced
October 8, 2019
Referred to the Subcommittee on Health.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House10/8/2019